Effect of Dexamethasone in the Development of O1 or O4 Immunoreactive Oligodendrocyte of the Neonatal Rat

김명주; Young Pyo Chang (장영표); 유영복; 최인영; 박기섭; 마스키 디라즈

doi:10.11637/aba.2009.22.4.305

Effect of Dexamethasone in the Development of O1 or O4 Immunoreactive Oligodendrocyte of the Neonatal Rat

Anatomy & Biological Anthropology
Abbr : Anat Biol Anthropol
2009, 22(4), pp.305~315
DOI : 10.11637/aba.2009.22.4.305
Publisher : 대한체질인류학회
Research Area : Medicine and Pharmacy > Anatomy

김명주 ¹, Young Pyo Chang ¹, 유영복 ¹, 최인영 ¹, 박기섭 ¹, 마스키 디라즈 ¹

¹단국대학교

Accredited

ABSTRACT

White matter disease (WMD) study, which underlies the subsequent progress of cerebral palsy as well as cognitive impairment of premature and/or low birth weight infants, has been focused either on the hypoxia-ischemia damage or cytokine-induced brain damage related with maternal or fetal inflammation. Also, dexamethasone (DEXA) may increase the risk of neuropsychological problem including adverse cognitive and behavioral outcome in preterm infants. Thus, we hypothesized that perinatal DEXA would damage and trigger the death of developing oligodendrocytes (OL) progenitors, and subsequently disturb myelination. In this study, DEXA was administered to neonatal rats for 3 consecutive days subcutaneously between postnatal day 1 (P1) and P3. By using immunofluorescent staining of stage specific OL progenitor markers such as O4 and O1, the morphological changes of OL progenitors were examined and the apoptosis of OL progenitors were visualized by TUNEL staining. Results depicted that relative number of O1 immunoreactive (IR) cells were less to that of O4 IR cells. Multipolar O1 IR cells with short dendritic processes were observed in both control and DEXA group at P3. In the total O1 immunoreactive cells, the relative percentages of apoptosis cells were calculated at P3 as 8.7% in control, 23.0% in DEXA group. The relative percentages of apoptosis in the total O4 immunoreactive cells were measured at P3 as 3.0% in control and 13.5% in DEXA group.OL progenitors’ apoptosis may contribute to the overall reduction of immature OLs in cerebral white matter. Therefore, specific stages of OL maturation could clinically be an important factor in determining the susceptibility to DEXA. To elucidate the disease mechanism of the white matter disease, further investigation may be needed whether OL progenitors’ decrease by the DEXA administration affects to the myelin formation as developmental stages.

KEYWORDS

White matter disease (WMD), Dexamethasone (DEXA), Oligodendrocytes (OL), O1, O4

Citation status

* References for papers published after 2023 are currently being built.

[confproc] Ahlbom E / 2000 / Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death / Proc Natl Acad Sci USA : 14726~14730

[journal] Back SA / 1998 / Maturation- dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion / J Neurosci 18 : 6241~6253

[journal] Back SA / 2002 / Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia / J Neurosci 22 : 455~463

[journal] Back SA / 2001 / Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury / J Neurosci 21 : 1302~1312

[journal] Baud O / 2004 / Postnatal steroid treatment and brain development / Arch Dis Child Fetal Neonatal Ed 89 : F96~F100

[journal] Baud O / 2007 / Corticosteroids in perinatal medicine: how to improve outcomes without affecting the developing brain? / Semin Fetal Neonatal Med 12 : 273~279

[journal] Benesová O / 1989 / Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain / Neuropharmacology 28 : 89~97

[journal] Bhutta AT / 2002 / Vulnerability of the developing brain. Neuronal mechanisms / Clin Perinatol 29 : 357~372

[journal] Committee on Fetus and Newborn / 2002 / Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants / Pediatrics 109 : 330~338

[journal] Craig A / 2003 / Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human / Exp Neurol 181 : 231~240

[journal] Dammann O / 2004 / Lung and brain damage in preterm newborns. Are they related? How? Why? / Biol Neonate 85 : 305~313

[journal] Debillon T / 2000 / Intrauterine infection induces programmed cell death in rabbit periventricular white matter / Pediatr Res 47 : 736~742

[journal] Eklind S / 2001 / Bacterial endotoxin sensitizes the immature brain to hypoxic--ischaemic injury / Eur J Neurosci 13 : 1101~1106

[journal] Fern R / 2000 / Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop / J Neurosci 20 : 34~42

[journal] Follett PL / 2000 / NBQX attenuates excitotoxic injury in developing white matter / J Neurosci 20 : 9235~9241

[journal] Gard AL / 1989 / Oligodendrocyte progenitors isolated directly from developing telencephalon at a specific phenotypic stage: myelinogenic potential in a defined environment / Development 106 : 119~132

[journal] Grier DG / 2005 / Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use / Drugs 65 : 15~29

[journal] Gu C / 1999 / Oligodendrocyte apoptosis mediated by caspase activation / J Neurosci 19 : 3043~3049

[journal] Gumbinas M / 1973 / The effects of corticosteroids on myelination of the developing rat brain / Biol Neonate 22 : 355~366

[journal] Hagberg H / 2002 / Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults / Ment Retard Dev Disabil Res Rev 8 : 30~38

[journal] Hauser J / 2008 / Effects of prenatal dexamethasone treatment on physical growth, pituitary-adrenal hormones, and performance of motor, motivational, and cognitive tasks in juvenile and adolescent common marmoset monkeys / Endocrinology 149 : 6343~6355

[journal] Kim MJ / 2007 / Expression of CD95 and CD95L on astrocytes in the CA1 area of the immature rat hippocampus after hypoxia-ischemia injury / Comp Med 57 : 581~589

[journal] Krägeloh-Mann I / 1995 / Bilateral spastic cerebral palsy-MRI pathology and origin. Analysis from a representative series of 56 cases / Dev Med Child Neurol 37 : 379~397

[journal] Kumral A / 2007 / Erythropoietin attenuates lipopolysaccharideinduced white matter injury in the neonatal rat brain / Neonatology 92 : 269~278

[journal] Lajic S / 2008 / Long-term outcome of prenatal treatment of congenital adrenal hyperplasia / Endocr Dev 13 : 82~98

[journal] Matthews SG / 1997 / CRH and AVP-induced changes in synthesis and release of ACTH from the ovine fetal pituitary in vitro: negative influences of cortisol / Endocrine 6 : 293~300

[journal] Murphy BP / 2001 / Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease / Pediatrics 107 : 217~221

[journal] Newnham JP / 2009 / Should we be prescribing repeated courses of antenatal corticosteroids? / Semin Fetal Neonatal Med 14 : 157~163

[journal] Nishiyama A / 1997 / Normal and reactive NG2+ glial cells are distinct from resting and activated microglia / J Neurosci Res 48 : 299~312

[journal] Pfeiffer SE / 1993 / The oligodendrocyte and its many cellular processes / Trends Cell Biol 3 : 191~197

[journal] Rajadurai VS / 2003 / The use and abuse of steroids in perinatal medicine / Ann Acad Med Singapore 32 : 324~334

[journal] Rangon CM / 2007 / Chronic mild stress during gestation worsens neonatal brain lesions in mice / J Neurosci 27 : 7532~7540

[journal] Saigal S / 2000 / School difficulties at adolescence in a regional cohort of children who were extremely low birth weight / Pediatrics 105 : 325~331

[journal] Tsuneishi S / 1991 / Effects of dexamethasone on the expression of myelin basic protein, proteolipid protein, and glial fibrillary acidic protein genes in developing rat brain / Brain Res Dev Brain Res 61 : 117~123

[journal] Uehara H / 1999 / A new model of white matter injury in neonatal rats with bilateral carotid artery occlusion / Brain Res 837 : 213~220

[journal] Volpe JJ / 2000 / Overview: normal and abnormal human brain development / Ment Retard Dev Disabil Res Rev 6 : 1~5

[journal] Weichsel ME Jr / 1977 / The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurological hazards / Ann Neurol 2 : 364~366

[journal] Whitaker AH / 1997 / Psychiatric outcomes in low-birth-weight children at age 6 years: relation to neonatal cranial ultrasound abnormalities / Arch Gen Psychiatry 54 : 847~856

[journal] Wilson TT / 2006 / Neurodevelopmental and respiratory follow-up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment) / Pediatrics 117 : 2196~2205

This paper was written with support from the National Research Foundation of Korea.

KJCKorea
Journal Central

Anatomy & Biological Anthropology 2023 KCI Impact Factor : 0.33

Effect of Dexamethasone in the Development of O1 or O4 Immunoreactive Oligodendrocyte of the Neonatal Rat

ABSTRACT

KEYWORDS

Citation status

* References for papers published after 2023 are currently being built.

Anatomy & Biological Anthropology 2023 KCI Impact Factor : 0.33

Effect of Dexamethasone in the Development of O1 or O4 Immunoreactive Oligodendrocyte of the Neonatal Rat

ABSTRACT

KEYWORDS

Statistics

Tools

Issue List

Citation status

KCI Citation Counts (0)

REFERENCES (39) * References for papers published after 2023 are currently being built.

Search PDF

Citation

* References for papers published after 2023 are currently being built.